Evaluation of age and sex differences in locomotion and catalepsy during repeated administration of haloperidol and clozapine in adolescent and adult rats.
Adolescence is associated with characteristic behavioral patterns as well as with substantial neuronal pruning and re-organization of the brain. Recent research has determined that the effects of various centrally active drugs differ in adolescents and adults. This study examined the motor effects of two prototypic antipsychotics in adult [>postnatal day 70 (PN70)] and adolescent (PN30-PN39) rats. Rats were injected daily with saline, 0.3 mg/kg haloperidol, or 10 mg/kg clozapine for 10 days and activity and catalepsy were measured. Adolescents of both sexes were less sensitive to the cataleptic effects of haloperidol than were adults. Male adolescents were also less sensitive to the cataleptic effects of clozapine, although this difference was transitory. In contrast, female adults showed decreased sensitivity to clozapine's effects, differing from all other groups. These results suggest that adolescents of both sexes may be less sensitive to the extrapyramidal motor effects of haloperidol. Translational implications of the clozapine results are less clear; however, results suggest that developmental differences in neurochemical systems affected by clozapine that are also related to motor behavior may play a role. These results also emphasize the importance of age and sex as determinants of the pharmacological effects of these antipsychotics.
Wiley
Jenny L
JL
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298-0613, USA. jwiley@vcu.edu
Evans
Rhys L
RL
D000375:Aging / Q000502:physiology* / Q000523:psychology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D002375:Catalepsy / Q000139:chemically induced* / Q000523:psychology; D003024:Clozapine / Q000494:pharmacology*; D004409:Dyskinesia, Drug-Induced / Q000523:psychology; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D051381:Rats; D020318:Rats, Long-Evans; D012727:Sex Characteristics
D014150:Antipsychotic Agents; D003024:Clozapine; D006220:Haloperidol
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
10817843
Psychopharmacology (Berl). 1983;81(3):239-43
6417713
Eur Neuropsychopharmacol. 2000 May;10(3):159-64
10793317
Schizophr Res. 2007 Aug;94(1-3):293-305
17574821
Psychopharmacology (Berl). 1999 Jan;141(3):267-78
10027508
Pharmacol Biochem Behav. 1993 Oct;46(2):405-9
8265695
Eur J Pharmacol. 2003 Jun 27;471(3):185-93
12826237
Psychopharmacology (Berl). 1981;73(3):219-22
6787640
Neuropsychopharmacology. 2006 Sep;31(9):1869-79
16237379
Psychopharmacology (Berl). 2006 Jul;186(4):579-86
16758242
Brain Res Mol Brain Res. 2002 Apr 30;100(1-2):75-83
12008023
Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73
8935801
Psychiatry Res. 1991 Aug;38(2):125-34
1754627
Psychoneuroendocrinology. 2002 Aug;27(6):683-91
12084661
Psychopharmacology (Berl). 1988;94(1):46-51
2894702
J Neurosci. 1985 Nov;5(11):2831-8
4056856
Eur J Pharmacol. 1992 Apr 29;215(1):29-34
1355442
Neurotoxicol Teratol. 2007 Jan-Feb;29(1):37-46
17049207
Brain Res Dev Brain Res. 2002 Sep 20;138(1):27-34
12234655
Psychiatr Clin North Am. 1993 Dec;16(4):779-91
8309812
Psychoneuroendocrinology. 1983;8(2):225-36
6353470
Neurochem Int. 1997 Mar;30(3):277-90
9041559
Psychopharmacology (Berl). 1984;82(4):406-8
6427835
Neuroreport. 1997 Apr 14;8(6):1495-8
9172161
Psychopharmacology (Berl). 1981;74(2):166-9
6791221
Neuropharmacology. 1988 Nov;27(11):1197-9
3205387
Arch Androl. 1997 Jul-Aug;39(1):79-83
9202837
Psychopharmacology (Berl). 1980;70(1):47-58
6775334
Can J Psychiatry. 2002 Feb;47(1):27-38
11873706
Brain Res Mol Brain Res. 1996 Sep 5;41(1-2):241-9
8883957
Pharmacol Biochem Behav. 1980 Nov;13(5):685-90
7192405
Behav Brain Res. 1989 Nov 1;35(2):95-109
2818834
Psychiatr Clin North Am. 1993 Dec;16(4):793-814
8309813
Cell Mol Neurobiol. 1996 Jun;16(3):325-44
8818400